Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, No. 2660, Vali-e-Asr Ave, Tehran, Iran.
World J Microbiol Biotechnol. 2020 Jun 25;36(7):96. doi: 10.1007/s11274-020-02872-9.
The innovative CRISPR-Cas based genome editing technology provides some functionality and advantages such as the high efficiency and specificity as well as ease of handling. Both aspects of the CRISPR-Cas9 system including genetic engineering and gene regulation are advantageously applicable to the construction of microbial cell factories. As one of the most extensively used cell factories, E. coli has been engineered to produce various high value-added chemical compounds such as pharmaceuticals, biochemicals, and biofuels. Therefore, to improve the production of valuable metabolites, many investigations have been performed by focusing on CRISPR-Cas- based metabolic engineering of this host. In the current review, the biology underlying CRISPR-Cas9 system was briefly explained and then the applications of CRISPR-Cas9/CRISPRi tools were considered for cell factory construction in E. coli.
基于 CRISPR-Cas 的基因组编辑技术具有高效性、特异性和易于操作等功能和优势。CRISPR-Cas9 系统的这两个方面,包括基因工程和基因调控,都有利于微生物细胞工厂的构建。作为应用最广泛的细胞工厂之一,大肠杆菌已被工程改造以生产各种高附加值的化合物,如药物、生物化学物质和生物燃料。因此,为了提高有价值代谢物的产量,许多研究都集中在基于 CRISPR-Cas 的该宿主的代谢工程上。在本综述中,简要解释了 CRISPR-Cas9 系统的生物学基础,然后考虑了 CRISPR-Cas9/CRISPRi 工具在大肠杆菌细胞工厂构建中的应用。